Drug Selection for Long-Term Anticoagulant Therapy in Patients with Venous Thromboembolism
Following completion of the primary phase of anticoagulant therapy (ACT) in patients with venous thromboembolic complications (VTEs), discontinuation of anticoagulant agents significantly increases the risk of recurrent venous thrombosis and pulmonary embolism. This consideration provides a compelling rationale for con...